Table of Contents
Hepatitis C in Children
Prevalence of Anti-HCV by Age (U.S.)
Proportion of Anti-HCV Seropositive Subjects in Pediatric Age Groups (U.S.)
Children at Risk for HCV Infection
Low Seroprevalence of Anti-HCV in Urban Adolescents
Frequency of Perinatal HCV Transmission
Perinatal HCV Transmission
Risk Factors for Perinatal HCV Transmission
Perinatal HCV Transmission from HIV Coinfected Women
Perinatal HCV Transmission Occurs Peripartum
Current Recommendations regarding Perinatal HCV Transmission
Clinical Features of HCV Infection in Children
Natural History of HCV Infection in Children - Critical Issues
Natural History of Transfusion-Acquired HCV in Children
HCV Infection Among Survivors of Childhood Cancer
Natural History of Perinatally Acquired HCV in Children
Comparison of Histopathologic Features of HCV Infection - Adults and Children
Histopathologic Features of HCV Infection in Children
Natural History of HCV Infection in Children - Summary
HCV in Childhood Goals of Therapy
Treatment of HCV Infection in Children Interferon Monotherapy
Interferon Monotherapy Trials in Children
Interferon Monotherapy in Children A Meta-analysis
Interferon Monotherapy Greater Efficacy in Children?
IFN Side Effects in Children
Ribavirin Toxicity
Rebetron Pediatric ClinicalTrials
Combination Therapy for Childhood HCV - Safety (Phase 1)
Phase I Clinical Trial Sustained Virologic Response
HCV in Childhood Therapeutic Considerations
|